Haemodialysis and peritoneal dialysis patients have severely impaired post-occlusive skin forearm vasodilatory response assessed with laser speckle contrast imaging

被引:20
作者
Alexandrou, Maria-Eleni [1 ,2 ]
Gkaliagkousi, Eugenia [3 ]
Loutradis, Charalampos [1 ]
Dimitriadis, Chrysostomos [1 ]
Mitsopoulos, Efstathios [2 ]
Lazaridis, Antonios [3 ]
Nikolaidou, Barbara [3 ]
Dolgiras, Panagiotis [3 ]
Douma, Stella [3 ]
Papagianni, Aikaterini [1 ]
Sarafidis, Pantelis A. [1 ]
机构
[1] Aristotle Univ Thessaloniki, Hippokrat Hosp, Dept Nephrol, Thessaloniki, Greece
[2] Papageorgiou Gen Hosp, Dept Nephrol, Thessaloniki, Greece
[3] Aristotle Univ Thessaloniki, Papageorgiou Gen Hosp, Dept Internal Med 3, Thessaloniki, Greece
关键词
endothelial dysfunction; end-stage renal disease; haemodialysis; laser speckle contrast imaging (LSCI); peritoneal dialysis; MICROVASCULAR ENDOTHELIAL DYSFUNCTION; FLOW-MEDIATED VASODILATION; STAGE RENAL-DISEASE; BLOOD-FLOW; ASYMMETRIC DIMETHYLARGININE; EUROPEAN-SOCIETY; WORKING GROUP; HYPERTENSION; MORTALITY; MICROCIRCULATION;
D O I
10.1093/ckj/sfaa136
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Endothelial dysfunction is associated with cardiovascular events and mortality in various disease states, including end-stage renal disease (ESRD). Novel technological approaches have emerged for real-time assessment of endothelial reactivity. This study examined skin microcirculation using laser speckle contrast imaging (LSCI) before and after arterial occlusion in ESRD patients undergoing haemodialysis (HD) or peritoneal dialysis (PD). Methods. The 38 HD patients were matched in a 1:1 ratio with 38 PD patients (for age, sex and dialysis vintage) and 38 controls (for age and sex). Skin microvascular reactivity parameters assessed with LSCI included baseline perfusion, occlusion perfusion and peak perfusion during post-occlusive reactive hyperaemia (PORH); time to peak perfusion; proportional change from baseline to peak perfusion; baseline and peak cutaneous vascular conductance (CVC); proportional change from baseline to peak CVC and amplitude of the PORH response (i.e. the difference between peak and baseline CVC). Results. Baseline perfusion [HD: 46.9714.6; PD: 49.32 +/- 18.07; controls: 42.02 +/- 11.94 laser specle perfusion units (LSPU), P=0.097] and peak post-occlusion perfusion (104.77 +/- 28.68 versus 109.04 +/- 40.77 versus 116.96 +/- 30.96 LSPU, P=0.238) did not differ significantly between groups. However, the post-occlusive vascular response was completely different since the proportional increase from baseline to peak perfusion (HD: 133 +/- 66; PD: 149 +/- 125; controls: 187 +/- 61%, P=0.001) was significantly lower in ESRD patients and time to peak response was lower in HD but similar in PD patients compared with controls (HD: 7.24 +/- 6.99; PD: 10.68 +/- 9.45; controls: 11.11 +/- 5.1s, Kruskal-WallisP =0.003; pairwise comparisons: HD versus controls, P=0.002; HD versus PD, P=0.154; PD versus controls, P=0.406). ESRD patients also had lower levels of peak CVC, indicating the maximum capillary recruitment (HD: 1.05 +/- 0.3; PD: 1.07 +/- 0.44; controls: 1.57 +/- 0.52 LSPU/mmHg, P<0.001), lower proportional increase of CVC at peak (P<0.001) and lower amplitude of the PORH response, a measure of the difference between baseline and maximum capillary recruitment (P=0.001). Conclusions. Using this novel non-invasive technology, endothelial post-occlusive forearm skin vasodilatory response was found to be similar between HD and PD patients and significantly impaired compared with controls. Future studies are needed to assess the prognostic implications of this microcirculatory functional defect.
引用
收藏
页码:1419 / 1427
页数:9
相关论文
共 45 条
[1]   Evaluation of Gastric Microcirculation by Laser Speckle Contrast Imaging During Esophagectomy [J].
Ambrus, Rikard ;
Achiam, Michael P. ;
Secher, Niels H. ;
Svendsen, Morten B. S. ;
Runitz, Kim ;
Siemsen, Mette ;
Svendsen, Lars B. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 225 (03) :395-402
[2]   Laser speckle contrast imaging in biomedical optics [J].
Boas, David A. ;
Dunn, Andrew K. .
JOURNAL OF BIOMEDICAL OPTICS, 2010, 15 (01)
[3]  
Borges JP, 2016, BRAZ J MED BIOL RES, V49, DOI [10.1590/1414-431X20165541, 10.1590/1414-431x20165541]
[4]   Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease - Additive value of flow-mediated dilation to ankle-brachial pressure index [J].
Brevetti, G ;
Silvestro, A ;
Schiano, V ;
Chiariello, M .
CIRCULATION, 2003, 108 (17) :2093-2098
[5]  
Briers J D, 1996, J Biomed Opt, V1, P174, DOI 10.1117/12.231359
[6]   Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension [J].
Brunner, H ;
Cockcroft, JR ;
Deanfield, J ;
Donald, A ;
Ferrannini, E ;
Halcox, J ;
Kiowski, W ;
Luscher, TF ;
Mancia, G ;
Natali, A ;
Oliver, JJ ;
Pessina, AC ;
Rizzoni, D ;
Rossi, GP ;
Salvetti, A ;
Spieker, LE ;
Taddei, S ;
Webb, DJ .
JOURNAL OF HYPERTENSION, 2005, 23 (02) :233-246
[7]   Arterial stiffness and functional properties in chronic kidney disease patients on different dialysis modalities: an exploratory study [J].
Chung, Ada W. Y. ;
Yang, H. H. Clarice ;
Kim, Jong Moo ;
Sigrist, Mhairi K. ;
Brin, Genevieve ;
Chum, Elliott ;
Gourlay, William A. ;
Levin, Adeera .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (12) :4031-4041
[8]   Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery - A report of the International Brachial Artery Reactivity Task Force [J].
Corretti, MC ;
Anderson, TJ ;
Benjamin, EJ ;
Celermajer, D ;
Charbonneau, F ;
Creager, MA ;
Deanfield, J ;
Drexler, H ;
Gerhard-Herman, M ;
Herrington, D ;
Vallance, P ;
Vita, J ;
Vogel, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (02) :257-265
[9]   Endothelial function and dysfunction - Testing and clinical relevance [J].
Deanfield, John E. ;
Halcox, Julian P. ;
Rabelink, Ton J. .
CIRCULATION, 2007, 115 (10) :1285-1295
[10]  
Della Rossa A, 2013, CLIN EXP RHEUMATOL, V31, pS109